Beyond the amyloid hypothesis: leveraging human-centered complex in vitro models to decode Alzheimer’s disease etiology
Beyond the amyloid hypothesis: leveraging human-centered complex in vitro models to decode Alzheimer’s disease etiology
Alzheimer’s disease (AD) is a complex neurodegenerative condition and the leading cause of dementia worldwide. Treatments that safely and effectively counteract disease progression are currently lacking. While the formation of amyloid plaques has long been considered the leading hypothesis of disease onset, growing evidence suggests that the emergence of AD could be driven by a combination of underlying factors that promote chronic neuroinflammation, including pathogenic infections, environmental toxicants, and disruptions along
the gut-brain axis. Traditional nonclinical models of AD, such as monolayer cell cultures and transgenic mice, struggle to capture the complexity of the disease as
it occurs in humans. Human-centered complex in vitro models (CIVMs), including
cerebral organoids and microfluidic organ-on-a-chip (OOC) technologies,
provide greater physiological relevance by more closely recapitulating key
cellular and molecular features of the human brain and disease mechanisms. In this mini review, we evaluate recent advances in CIVMs and how they are being
leveraged to investigate emerging hypotheses of AD etiology. Cerebral organoids
and OOC platforms can consistently replicate neuropathological hallmarks of
neurodegeneration in response to pathogenic or environmental insults, including
blood-brain barrier disruption, amyloid-β accumulation, tau
hyperphosphorylation, and glial activation. We also highlight early efforts to
model the gut–brain axis using organoid and multi-OOC systems,
demonstrating how microbiota-derived factors can affect neural processes. Collectively, these studies show that human-centered CIVMs can be applied
to both recreate and mechanistically disentangle interrelated pathological
processes to an extent beyond that afforded by animal models, thus offering
new opportunities to identify causal mechanisms and potential therapeutic
targets.
Alzheimer’s disease (AD), Complex in vitro models, Environmental toxicants, Gut-brain axis, Infectious hypothesis, Neuroinflammation, Organ-on-a-chip, Organoids
Price, Matthew
71efb307-0408-4f46-be2b-2d012ec71722
Pistollato, Francesca
433f7d23-da62-453a-adda-03e94ea37b02
9 January 2026
Price, Matthew
71efb307-0408-4f46-be2b-2d012ec71722
Pistollato, Francesca
433f7d23-da62-453a-adda-03e94ea37b02
Price, Matthew and Pistollato, Francesca
(2026)
Beyond the amyloid hypothesis: leveraging human-centered complex in vitro models to decode Alzheimer’s disease etiology.
Frontiers in Toxicology, 7, [1753572].
(doi:10.3389/ftox.2025.1753572).
Abstract
Alzheimer’s disease (AD) is a complex neurodegenerative condition and the leading cause of dementia worldwide. Treatments that safely and effectively counteract disease progression are currently lacking. While the formation of amyloid plaques has long been considered the leading hypothesis of disease onset, growing evidence suggests that the emergence of AD could be driven by a combination of underlying factors that promote chronic neuroinflammation, including pathogenic infections, environmental toxicants, and disruptions along
the gut-brain axis. Traditional nonclinical models of AD, such as monolayer cell cultures and transgenic mice, struggle to capture the complexity of the disease as
it occurs in humans. Human-centered complex in vitro models (CIVMs), including
cerebral organoids and microfluidic organ-on-a-chip (OOC) technologies,
provide greater physiological relevance by more closely recapitulating key
cellular and molecular features of the human brain and disease mechanisms. In this mini review, we evaluate recent advances in CIVMs and how they are being
leveraged to investigate emerging hypotheses of AD etiology. Cerebral organoids
and OOC platforms can consistently replicate neuropathological hallmarks of
neurodegeneration in response to pathogenic or environmental insults, including
blood-brain barrier disruption, amyloid-β accumulation, tau
hyperphosphorylation, and glial activation. We also highlight early efforts to
model the gut–brain axis using organoid and multi-OOC systems,
demonstrating how microbiota-derived factors can affect neural processes. Collectively, these studies show that human-centered CIVMs can be applied
to both recreate and mechanistically disentangle interrelated pathological
processes to an extent beyond that afforded by animal models, thus offering
new opportunities to identify causal mechanisms and potential therapeutic
targets.
Text
ftox-7-1753572
- Version of Record
More information
Accepted/In Press date: 15 December 2025
Published date: 9 January 2026
Keywords:
Alzheimer’s disease (AD), Complex in vitro models, Environmental toxicants, Gut-brain axis, Infectious hypothesis, Neuroinflammation, Organ-on-a-chip, Organoids
Identifiers
Local EPrints ID: 509969
URI: http://eprints.soton.ac.uk/id/eprint/509969
ISSN: 2673-3080
PURE UUID: d0702a96-4721-454b-a5e5-1dbc64b498cf
Catalogue record
Date deposited: 11 Mar 2026 17:53
Last modified: 11 Mar 2026 17:55
Export record
Altmetrics
Contributors
Author:
Matthew Price
Author:
Francesca Pistollato
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics